Cargando…
Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients
The management of myeloma in the elderly is shifting its focus towards reducing the risk of under-treating fit patients and the risk of over-treating frail patients. Frailty assessment is required in this patient group in order to individualise treatment decisions. In addition to the proven prognost...
Autores principales: | Djebbari, Faouzi, Rampotas, Alexandros, Panitsas, Fotios, Lim, Wen Yuen, Lees, Charlotte, Tsagkaraki, Ismini, Gomes, Ana Rita, Prideaux, Steve, Chen, Lucia, Prodger, Catherine, Khera, Akhil, Gray, Nicola, Ellis, Lauren, Sangha, Gina, Eyre, Toby A., Moore, Sally, Kothari, Jaimal, Ramasamy, Karthik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752006/ https://www.ncbi.nlm.nih.gov/pubmed/35015781 http://dx.doi.org/10.1371/journal.pone.0262388 |
Ejemplares similares
-
Infection-related morbidity in a large study of transplant non-eligible newly diagnosed myeloma patients treated with UK standard of care
por: Djebbari, Faouzi, et al.
Publicado: (2020) -
Clinical outcomes of bortezomib-based therapy in myeloma
por: Djebbari, Faouzi, et al.
Publicado: (2018) -
Efficacy of Isatuximab With Pomalidomide and Dexamethasone in Relapsed Myeloma: Results of a UK-Wide Real-World Dataset
por: Djebbari, Faouzi, et al.
Publicado: (2022) -
Treatment-free interval as an additional measure of efficacy in a large UK dataset of transplant ineligible myeloma patients
por: Djebbari, Faouzi, et al.
Publicado: (2020) -
Acquired platelet dysfunction in newly diagnosed myeloma
por: Mortimer, Joshua, et al.
Publicado: (2021)